ERNA 10-Q: SEC filing
Ernexa Therapeutics
Filed with the SEC on · accession 0001493152-26-050501
ERNA filed a 10-Q (quarterly report) with the SEC on Nov 6, 2026. Ernexa Therapeutics filed a Form 10-Q quarterly report for the period ended September 30, 2026, accompanied by the standard Sarbanes-Oxley Section 302 certification from CEO Sanjeev Luther.
Summary of the filing
Ernexa Therapeutics filed a Form 10-Q quarterly report for the period ended September 30, 2026, accompanied by the standard Sarbanes-Oxley Section 302 certification from CEO Sanjeev Luther. The certification confirms the financial statements fairly present the company's financial condition and that disclosure controls are effective.
Key details
✦ Ask GOAX AI about this filing — what it means for ERNA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ERNA?
Click hereFrequently asked questions
What did ERNA file with the SEC on Nov 6, 2026?
ERNA filed a 10-Q (SEC filing). Ernexa Therapeutics filed a Form 10-Q quarterly report for the period ended September 30, 2026, accompanied by the standard Sarbanes-Oxley Section 302 certification from CEO Sanjeev Luther. The certification confirms the financial statements fairly present the company's financial condition and that disclosure controls are effective.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Other ERNA SEC filings
Get alerts when ERNA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days